2000Unpublished venueRequires access

Pharmacokinetics and Relative Bioavailability of Domestic Levofoxacin Distributive Tablet in Healthy Volunteers

Wenxiu Han

Open publisher page 0 citations

Abstract

OBJECTIVE:The pharmacokinetics and relative bioavailability of domestic levofoxacin distributive tablet in healthy volunteers were studied METHODS: A single oral 200mg dose of domestic levofoxacin distributive tablet or imported levofoxacin tablet was given to 12 healthy male volunteers in a randomized cross-over clinical study The serum concentrations of levofoxacin were determined by HPLC The pharmacokinetics parameters were analyzed by 3p97 computer software RESULTS:The serum concentration-time curve fitted to two compartment model,and the main pharmacokinetic parameters of domestic distributive tablet and imported tablet were as follows respectively Cmax=(1 14±0 29)mg/L and (1 18±0 31)mg/L,Tmax=(1 05±0 87)h and (1 04±0 83)h,AUC=(6 92±2 19)mg/(L·h) and (6 92±2 04)mg/(L·h) The relative bioavailability of domestic was (100 8±17 69)% There were no significant difference between the domestic distributive tablet and imported tablet CONCLUSION:The domestic distributive tablet and imported tablet are bioequivalent

About this research paper

What this paper is about

OBJECTIVE:The pharmacokinetics and relative bioavailability of domestic levofoxacin distributive tablet in healthy volunteers were studied METHODS: A single oral 200mg dose of domestic levofoxacin distributive tablet or imported levofoxacin tablet was given to 12 healthy male volunteers in a randomized cross-over clinical study The serum concentrations of levofoxacin were determined by HPLC The pharmacokinetics parameters were analyzed by 3p97 computer software RESULTS:The serum concentration-time curve fitted to two compartment model,and the main pharmacokinetic parameters of domestic distributive tablet and imported tablet were as follows respectively Cmax=(1 14±0 29)mg/L and (1 18±0 31)mg/L,Tmax=(1 05±0 87)h and (1 04±0 83)h,AUC=(6 92±2 19)mg/(L·h) and (6 92±2 04)mg/(L·h) The relative bioavailability of domestic was (100 8±17 69)% There were no significant difference between the domestic distributive tablet and imported tablet CONCLUSION:The domestic distributive tablet and imported tablet are bioequivalent

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:The pharmacokinetics and relative bioavailability of domestic levofoxacin distributive tablet in healthy volunteers were studied METHODS: A single oral 200mg dose of domestic levofoxacin distributive tablet or imported levofoxacin tablet was given to 12 healthy male volunteers in a randomized cross-over clinical study The serum concentrations of levofoxacin were determined by HPLC The pharmacokinetics parameters were analyzed by 3p97 computer software RESULTS:The serum concentration-time curve fitted to two compartment model,and the main pharmacokinetic parameters of domestic distributive tablet and imported tablet were as follows respectively Cmax=(1 14±0 29)mg/L and (1 18±0 31)mg/L,Tmax=(1 05±0 87)h and (1 04±0 83)h,AUC=(6 92±2 19)mg/(L·h) and (6 92±2 04)mg/(L·h) The relative bioavailability of domestic was (100 8±17 69)% There were no significant difference between the domestic distributive tablet and imported tablet CONCLUSION:The domestic distributive tablet and imported tablet are bioequivalent

Key concepts: Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Distributive property, Pharmacology, Medicine, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Relative Bioavailability of Domestic Levofoxacin Distributive Tablet in Healthy Volunteers — Research Paper | ScholarLens